Cyteir Therapeutics, Inc. announced the appointment of John F. Thero to its board of directors. Mr. Thero will chair the audit committee. His appointment will increase the number of Cyteir board directors from eight to nine.

Mr. Thero is an accomplished financial and operations executive with more than 30 years of experience in senior roles, including more than 20 years supporting the growth of life science companies. In 2019, Mr. Thero was named Ernst & Young LLP Entrepreneur of the Year for Life Sciences. From 2009, until he elected to retire in August 2021, Mr. Thero was an executive officer at Amarin Corporation PLC, including serving as President since 2010 and as Chief Executive Officer and a member of its board of directors since 2014.

During his tenure at Amarin, he helped successfully lead the company through clinical development, global regulatory approvals, and commercialization of VASCEPA®. Prior to Amarin, Mr. Thero served as Chief Financial Officer (CFO) at ViaCell, Inc., where he helped guide the company in its sale to PerkinElmer, and Abiomed, Inc., where he held multiple positions, including Senior Vice President of Business Operations and CFO. Mr. Thero began his professional career at Arthur Andersen LLP.

He received a B.A. in Economics and Accounting from The College of the Holy Cross in Worcester, Massachusetts. He is currently a member of the board of directors at CinCor Pharma, Inc.